• Latest Posts

FDA approves Beyfortus ahead of 2023-24 RSV season

World’s first RSV vaccine for older adults gets FDA approval

Poolbeg identifies new potential drug candidates for RSV infections 

Nuance Pharma’s RSV vaccine cleared for trial in China


RSV cases are rising fast in children. Early detection can help.

Interview 14 Nov 2022

In depth interview: AstraZeneca/Sanofi RSV drug Beyfortus

AI program yields multiple novel RSV drug targets

More News! 4 Nov 2022

Sanofi and AstraZeneca drug, Beyfortus, for RSV in babies and children approved

Virax Biolabs introduces flu, Covid-19 and RSV rapid test kits

Beyond Biotech podcast 6: Mogrify, +ND Capital, Poolbeg Pharma